We have produced resources about lecanemab for you and your patients. Find out more below. Donanemab (brand name Kisunla®) is a new medication used to treat the very early stages of Alzheimer's ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...

Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities. Facts Alzheimer’s disease is the most common form of dementia, which ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...

Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer's disease, offering hope for slowing its progression. T ...